IL6 and breast carcinoma: miR-5112 is upregulated in breast cancer tissues, where it targets the cytoplasmic polyadenylation element-binding protein 1 (CPEB1) that serves as an internal inhibitor of the pro-inflammatory cytokine IL-6 (29, 30).